Evidence Hub

Spared cognitive and social function following perinatal ablation of ATRX despite transient microglia dysregulation

Mansour KY, Pena-Ortiz MA, Wu J, Shafiq S, Bérubé NG

Scientific reports, 2026

Abstract

Mutations in the chromatin-remodelling factor ATRX cause syndromic intellectual disability (ID) and autism spectrum disorder (ASD), but the role of microglial ATRX in early brain development remains poorly understood. Here, we used a tamoxifen-inducible Cx3cr1-CreERT2 system to delete Atrx specifically in microglia during the first postnatal week. High recombination efficiency was achieved by one month of age; however, knockout efficiency declined by three months to approximately 20% in the cortex and 40% in the hippocampus, suggesting repopulation by wild-type microglia. ATRX-deficient microglia exhibit an increase in CD68-positive foci, greater ramification complexity, and enlarged cell volume, consistent with a reactive phenotype. Furthermore, we observed an elevated proportion of Ki67-positive proliferative microglia at both one and three months of age. To assess the functional consequences of these cellular alterations, we evaluated juvenile and adult ATRX microglial knockout (mi-KO) and control mice across a behavioural battery assessing anxiety-like behaviour, locomotion, learning and memory, social interaction, and sensory gating. No significant genotype-dependent differences were detected across these domains. Together, these findings indicate that perinatal loss of ATRX in microglia induces a reactive phenotype and turnover without measurable impacts on neurobehavioural outcomes, suggesting developmental resilience of neural circuits to transient microglial…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free